Doglio, M. http://orcid.org/0000-0003-2477-2139
Ugolini, A.
Bercher-Brayer, C.
Camisa, B.
Toma, C.
Norata, R.
Del Rosso, S.
Greco, R. http://orcid.org/0000-0002-6117-5328
Ciceri, F. http://orcid.org/0000-0003-0873-0123
Sanvito, F. http://orcid.org/0000-0002-4046-8420
Casucci, M. http://orcid.org/0000-0003-4500-9060
Manfredi, A. A. http://orcid.org/0000-0001-8370-6970
Bonini, C. http://orcid.org/0000-0002-0772-1674
Article History
Received: 14 September 2022
Accepted: 26 February 2024
First Online: 27 March 2024
Competing interests
: BC, CF are inventors on different patents on cancer immunotherapy and genetic engineering. BC has been member of Advisory Board and Consultant for Molmed, Intellia, TxCell, Novartis, GSK, Allogene, Kite/Gilead, Miltenyi, Kiadis, Evir, Janssen and received research support from Molmed s.p.a and Intellia Therapeutics. The other authors declare no competing interests.